There are 2867 resources available
1535P - Efficacy and safety of amrubicin after treatment with immune checkpoint inhibitor combined with chemotherapy in extensive-stage small cell carcinoma: MiSSION1
Presenter: Tadashi Nishimura
Session: Poster session 05
1538P - Prognostic impact of leptin (LEP)-mediated meta-inflammation (MI) in patients (pts) receiving maintenance immunotherapy (IT) for extensive-stage small cell lung cancer (ES-SCLC)
Presenter: Emanuele Vita
Session: Poster session 05
1539P - Real-world (RW) outcomes of second-line (2L) small cell lung cancer (SCLC) patients treated with lurbinectedin
Presenter: Adina Estrin
Session: Poster session 05
1540P - Real-world analysis of outcomes of first-line chemo-immunotherapy in patients with extensive disease small cell lung cancer (ED-SCLC)
Presenter: Núria Zellweger
Session: Poster session 05
1541P - Real-world data of atezolizumab plus carboplatin-etoposide for patients with extensive stage SCLC: The UK experience
Presenter: Laura Moliner
Session: Poster session 05
1542P - First real-world outcome data of SCLC in Germany: Data from the Clinical Research platform Into molecular testing, treatment and outcome of (non-)Small cell lung carcinoma Patients (CRISP; AIO-TRK-0315)
Presenter: Martin Sebastian
Session: Poster session 05
1543P - A retrospective cross-sectional study of treatment patterns in small cell lung cancer (SCLC) in Europe 2018–2021
Presenter: Noemi Reguart Aransay
Session: Poster session 05
1544P - Pre-treatment CT radiomics predicts survival in chemo-immunotherapy-treated small cell lung cancer
Presenter: Joseph Bae
Session: Poster session 05
1545P - A multicenter prospective observational study of pre-existing autoantibodies in patients with small cell lung cancer treated with ICI
Presenter: Yuki Sato
Session: Poster session 05